Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks.

We’re delighted that NICE has approved bevacizumab for first- and second-line treatment in combination with chemotherapy for advanced bowel cancer patients in England and Wales, following a similar ...

EDX Medical Group announces the commercial launch in the UK of a new comprehensive testing service that improves the early ...

The overall incidence of colorectal cancer (CRC) in the United Kingdom plateaued at 67.4 per 100,000 person-years from 2000 to 2021, with slight improvements observed in overall survival, particularly ...

Cases of bowel cancer in people aged 25 to 49 have risen 24 per cent in the UK since 1995, despite falling rates in older ...

The aim of the current study is to report the long-term outcomes after laparoscopic-assisted surgery compared with conventional open surgery within the context of the UK MRC CLASICC trial. Results ...

A new, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks.The service increases ...